Apollo Newsletter_A4_09032016

Apollo
Research and
Innovations ( ARI)
A division of Apollo Hospitals Enterprise Ltd.
Research &
Innovation
Bulletin
2016
“Every great advance in science has issued from a new
audacity of imagination” – John Dewey

Apollo Research Bulletin
Vision
“
Enable a Research & Innovations led
Apollo Hospitals, which consistently rides
the cutting edge in Technology, Therapy,
Delivery for improved patient outcomes,
affordability and reach.
”
Quick
Facts
• Dedicated umbrella organization for spearheading
Research and Innovations for Apollo.
• Unmatched experience from 800 clinical studies.
• Diverse portfolio : Drugs, Software, Devices &
others.
Inside
2

From the desk of …
Apollo Research Bulletin
This edition of the research newsletter is dedicated to our beloved Padmashree
Prof. Ranjit Roy Chaudhury ….
Prof. Ranjit Roy Chaudhury; an iconic individual, had
joined our family in 2003 as the Chairman - Task Force
for Research, Apollo Hospitals. He was at the forefront
of bringing pioneering change in healthcare for more
than 40 years as the Chairman, Clinical Trials & Ethics
Sub-Committee, Ministry of Health and Family Welfare,
Government of India.
We express our deepest and heartfelt condolences to his
family, friends and colleagues and pray for his soul to rest
in peace.
“ARI is dedicated to spawning Research and Innovation
within the Apollo ecosystem and such endeavours are
likely to become cornerstones to prepare the hospital
group for next generation. Having already created some
momentum in introducing genetics and medical device
innovations, we are moving on to a very exciting times
ahead. In the coming year we are likely to see introduction
of pharmacogenetics and liquid biopsies which shall push
the envelope in personalized medicine and diagnostics. “
Dr. Prathap C Reddy
Founder-chairman,
Apollo Hospitals
Ms. Shobana Kamineni
Executive Vice chairperson,
Apollo Hospitals
“We at Apollo believe that a research led hospital shall
differentiate us sustainably. In this context, the research
foundation and the research related joint ventures shall
contribute significantly in introducing disruptive innovation
in our ecosystem. We have already observed traction in
terms of establishing a Biobank, introducing genetics
through APHC, DNA+, commencing device innovations
and etc. The effort no doubt requires patience, diligence
and a vision. I look forward to each one of you to play a
distinct role in furthering realization of this vision.”
3

Research at Apollo: Portfolio Snapshot
Apollo Research Bulletin
ARI has been mandated to consolidate the research efforts through various
research ventures and initiatives across Apollo Hospitals. ARI is focused on leading
Clinical Research and Innovations, Basic and Public Research, Technology/
therapy validation, Incubation, Deal Structuring and co-development of intellectual
property.
4

Research at Apollo: Portfolio Snapshot
Apollo Research Bulletin
Apollo Research and Innovations:
An Ecosystem… Real & Thriving !!!
5

Cover Story
Apollo Research Bulletin
Introduction of Genetics at Apollo
Pioneering New Age of Healthcare in India
Genomic testing involves analyses of patient genomes and translating insights gained
from the analysis to develop better healthcare interventions. This is done by way of
prognostic tools for improved disease screening/prevention strategies, better diagnostic
tests for optimization of clinical care, better theranostic tests for personalization of
treatment and monitoring of outcomes.
Our vision for genetics is predictive testing, pharmacogenetics & sensitivity
and Disruptive cancer detection.
Apollo Hospitals is committed to translating research into clinical outcomes for patient
benefit. With this aspiration, Apollo Hospitals through ARI, incubated and launched
Sapien Biosciences as a first step in this direction. Sapien shall focus on creation of
a national bio-repository and derivative products and services. These products and
services shall augment personalized medicine and bridge the gap with Life sciences.
Apollo Hospitals offers DNA+ as a part of Personalized health
Check
As a part of predictive genetic screening, Apollo
Hospitals has partnered with Datar Genetics to offer
a comprehensive Disease Predisposition Gene Test
(DNA+), for the first time in India. This one time test
will analyze and assess unique DNA make-up to
understand its impact on genetic predisposition for
more than 60 conditions including cardiovascular
disease, diabetes and cancers. ARI has assisted in
commercialization and deployment of DNA+ as part of
Apollo Personalized health checks (APHCs).
MyPLATELET
Sapien and AHERF launched its first and novel personalized medicine diagnostic test
“myPLATELET” at Apollo Hyderabad and Bhubaneswar. The test helps to determine
patient’s response to their blood-thinning medication and supports decision-making
by the cardiologists to personalize therapy for better outcomes. This is the only test
in India that combines both genetic and platelet function response to enable tailored
anti-platelet therapy for each patient. 300 diagnostic tests have been undertaken so
far.
6

Cover Story
Apollo Research Bulletin
Liquid Biopsy for Brain Tumors
AHERF researchers along with clinicians from Apollo Hospitals have established and
developed a liquid biopsy diagnostic for brain tumours. AHERF has collaborated with
Datar Genetics Ltd; a leading genetics service provider, to validate a non invasive
blood based diagnostic of Glioblastomas (the most fatal and aggressive type of brain
tumour). Both organizations have co-validated the assay and the path breaking test is
likely to be introduced first at Apollo in February 2016. The liquid biopsy is one of the
top 15 breakthrough technologies of 2015(MIT Tech Review). It places Apollo at the
global forefront in research.
Upcoming Projects in Genetics
Urine based test for cervical cancer
A leading U.S. based genetics company has developed
a urine based HPV HR test for the screening of cervical
cancer using DNA sequencing. ARI is working closely
with Sapien in finalizing the collaboration. We believe
that leveraging this technology cervical cancer
screening will increase manifold. This shall enable us
to diagnose & treat cervical cancer in time and there
by impacting incidence nationally.
Reccurence Monitoring for Breast cancer
OncoStem Diagnostics is a US-India clinical diagnostic start-up. Sapien is collaborating
with Oncostem to validate & launch a novel recurrence prediction test for breast cancer.
The project is expected to be launched in India by May 2016.
7

Global Reach
Apollo Research Bulletin
Cross-country Reach out: Israel Medical device companies
Apollo Research and Innovations (ARI) proactively
contacted the Israel Trade Commission for getting
medical devices studies at Apollo.
17 companies from Israel evinced interest for
validation of medical devices and 4 of these
projects are in progress/completed in one or more
of our hospitals. Early Sense & Sight Diagnostics
are likely to be deployed in hospital shortly.
Global Alliance : Apollo Hospitals and HealthXL
Apollo Hospitals enabled by ARI has recently joined
HealthXL, a global forum for Healthcare innovation
that converges healthcare professionals, medical
device and diagnostics providers to ideate, design
and propose solutions to various healthcare
challenges.
HealthXL is unique community comprising of
marquee partners such as Cleveland clinic, UCLA,
Merck, Ernst & Young, IBM, Google etc. dedicated
to healthcare innovation.
This association will enable Apollo clinicians,
paramedics and administrators to be aligned with
cutting edge developments in healthcare and will
also present us with opportunities to participate in
international projects on healthcare with diverse
teams across organisations & geographies.
AAHRPP accreditation : Global gold standard for clinical
research
ARI has applied for AAHRPP accreditation which is the global gold standard for
clinical research. Hence, preparing Apollo with rigorous standards for ethics, quality,
and protections of human research. AAHRPP
accreditation will earn us a place among the
world’s most respected, trustworthy research
organizations. For the time in AAHRPP’s history, 5
hospitals from the same hospital group are being
considered for accreditation. This will make us one
of few front runners in India.
8

In the Spotlight
Apollo Research Bulletin
Healthcare Innovation Accelerator
Apollo hospitals is in process of exploring a
healthcare Innovation fund for start-ups. Such a
framework will allow Apollo to proactively identify
disruptive innovations constantly whilst connecting
with a global network. Such innovation shall be
oriented towards solving problems faced by the
lower and middle income countries (LMIC).
Early Sense: A unique monitoring device for oncology wards
Apollo Hospitals is shortly set to
introduce a cutting edge Israeli
technology called Early Sense. The
system is intended to monitor and track
patients’ heart rate, respiratory rate,
and patient’s mobility to early sense
developing complications and early
intervene to prevent any fatal events.
ARI has completed a pilot study for
clinical validation of the product.
The technology will add significant value when introduced in oncology ward enabling
Apollo to take extra care of it patients
Eris: Single Largest Study including 100 Principal Investigator
This is one of its kind of Study has been conducted
with an objective to assess the comparison of
Ambulatory Blood Pressure Monitoring (ABPM)
versus Office Blood Pressure Monitoring (OBPM)
in patients with newly diagnosed, controlled and
uncontrolled hypertension. This study has been
by 100 investigators across 8 sites pan-India.
Conducted. The vision is to change the paradigm
of hypertension management, based on patterns
emerging from hypertension data.
9

Other key Projects & Activities
Apollo Research Bulletin
Sapien Biosciences
Sapien Biosciences is a joint venture between Apollo Hospitals & Saarum Innovations,
creating a world-class bio-bank and providing personalized medicine solutions.
Sapien’s focus is to develop novel clinical and R&D applications. Through its sister
concern Saarum Sciences, Sapien also intends to partner with healthcare enterprises
and drug discovery companies globally to study disease epidemiology, develop
new cell lines, create cell based platforms, assist in drug screening, discover new
biomarkers etc.
Sapien has already rolled out genetic tests myPLATELET and myCarDiOTM so as to
create momentum in this new space. Further, Sapien has forged a key collaboration
with Oncostem diagnostics, a Bangalore based organization focused on oncology
biomarkers. Currently both companies are working together to a breast cancer
recurrence prognostic biomarker. This test is likely to be available at a fraction of the
cost. For existing breast cancer survivors/patients it will enable personalized monitoring
and intervention.
Collaboration with Medtronic
ARI hand held the Medtronic project from concept
to an advanced stage of commercial negotiations.
Facilitating an interface with our clinicians and
administrators, ARI assited Medtronic to converge
clinical and operational challenges to create an
aspirational dialysis product. The current prototype
consumes only 6 liters of purified water vs. 120
liters used by a conventional device. The vision is
to enable dialysis for patients, using minimal water.
The project has now been transitioned to AHLL for
realization.
Clinical validation of Innovative Knee
Brace at Apollo
Unloader One is a knee brace for Osteoarthritis
patients. The braces helps in prolonging the time
to surgery for OA I and II patients. The brace
is uniquely designed to help in increasing the
space between the joints and have an additional
silicon coating internally to reduce rashes. ARI
has successfully completed a pilot study for the
validation of Unloader One OA.
10

Other key Projects & Activities
Apollo Research Bulletin
USV – Investigator Initiated Study for
Type II Diabetes Drug
Apollo has recently signed an agreement with USV
for a phase IV Investigator Initiated Study in Type 2
diabetes in Indian population. The study duration
is 1 year and is being conducted by 5 investigator
across 4 Apollo centers. It is one of the larger studies
initiated by investigators.
Genpraxis – Remote Genetic Counseling Platform
Genpraxis is a provider of next generation
sequencing clinical diagnostics for inherited disease
and precision medicine. It is entering into remote
genetic counseling sector where single platform will
provide one stop shop for physician and patients.
ARI has assisted HNG in closing a term sheet to
realize this venture. The Genepraxis is a spin off
from Yale University & shall enable opening a larger
collaboration.
Lipotest Meal - Diagnostic meal for performing Fat Tolerance
Test
The test is developed by D-Genomeres, Greece. The Lipotest-meal is a diagnostic
meal used for diagnosing the abnormal postprandial lipaemia (Fat Tolerance Test). It
is the meal that someone consumes in order to perform the Fat Tolerance Test. The
lipo-test meal used in OFTT is a diagnostic tool which is given as a mousse in fasting
condition to patients.
ARI has completed the study and the outcome are
in line with the current knowledge.
In the absence of a standardized fat tolerance test
in India, Lipotest meal provides an opportunity
to test the postprandial lipemia as a risk factor
for cardiovascular disease.
11

Upcoming
Apollo Research Bulletin
Digital India: Enabling accessible Healthcare via Drones
Apollo’s vision to enhance healthcare reach to the
last mile has gathered further momentum with a
concept being created to use unmanned aerial
vehicles (UAVs). More popularly known as drones,
these UAVs have potential to travel at over 60 miles/
hour and enable sample collection and medicine
delivery quickly. Such a precise point to point
aerial medium for transportation becomes critical
in difficult terrains or inaccessible areas. Further
scope includes emergency services (defibrillation)
and augments Telemedicine. A concept proposal
has been created with a U.S. Based start-up and submitted to the Director General
Civil Aviation (DCGA). If realised Apollo would pioneer a disruptive way to enhance
healthcare reach.
Biopmedical: Israeli technology for cervical cancer screening
An Israeli medical device start up, Biopmedical
has developed a digital portable optical probe for
screening and diagnosis of cervical cancer using
optical signatures. Biop was accepted for IBM’s
first ever accelerator program. Ginni Rometty, CEO
of IBM, mentioned Biopmedical as a “promising”
company in her speech. The device provides a
360 degree, high resolution view of the cervix by
recording four optical characteristics of the scanned
tissue. ARI has completed the technical evaluation
for the device. ARI is in process to commence a
clinical validation study for the device.
Sight Diagnostics: 2 minutes Point of care Malaria diagnosis
Apollo is collaborating with SightDx for introducing
an image-processing device; Parasight Platform
for blood analysis. Parasight combines cutting
edge computer vision algorithms, custom low cost
hardware and novel blood preparation techniques to
detect malaria in a rapid, reliable and completely
automated fashion. ARI has successfully completed
a pilot study for clinical validation of the product and
has facilitated discussion at Apollo. This technology
shall allow Apollo to introduce a much more efficient,
potable and accurate malaria diagnostic system to India.
12

Events
Apollo Research Bulletin
1st ever Healthcare Devthon organized at Apollo Hospitals
BioAsia hosted a Healthcare Devthon in association with Apollo Hospitals. It was
a co-creation exercise that brought healthcare experts, engineers, technologists
and developers together onto a platform to discover, design and rapidly prototype
technologies and solutions in the life sciences and healthcare fields. The event took
place in 4 phases namely; Domain immersion, Design thinking & ideation, Prototyping
and Showcasing at BioAsia 2015. 150 innovators participated in the event held at
Apollo Medical College, Hyderabad. The Healthcare Devthon also facilitated meaningful
interactions between the participants and doctors from Apollo hospitals which helped
them gather insights into the functioning and understand on-ground challenges.
13

Events
Apollo Research Bulletin
ARI hosted International Clinical trial day with ISCR
ARI team hosted the ‘International Clinical
trial day’ celebration at Apollo Health City,
Hyderabad in collaboration with Navchetna
(an awareness & Advocacy Initiative for
Clinical Research by Indian Society for
Clinical Research), KIMS and NIMS. Over
85 investigators, study coordinators,
Ethics committees, students, patients
and regulatory representative participated
in the event. The event commenced with
a welcome note by Dr. Ravindra Babu,
Medical. Superintendent, Apollo Hospitals,
Hyderabad. The clinical research
team at ARI introduced the concept of
International Clinical Trials Day and the
Clinical research film by ISCR. There were
several investigators and patients who
shared their stories and experiences of
participating in the clinical trials.
ISCR-Apollo Pharmacovigilance Symposium held at Apollo
Chennai
ARI organized a seminar on ‘Best Practices
in Pharmacovigilance for Healthcare
Professionals in Contemporary Indian
Scenario’ in association with Indian
Society for Clinical Research(ISCR) at
Apollo Main Hospital, Chennai on 29th
July 2015.
The event was attended by doctors,
clinical pharmacists, senior nurses,
pharmacologists, Clinical Research Team
members and also ISCR Members and
representatives of ISCR’s Accredited
Member Organizations (AMOs).
There were thoughts shared by healthcare
professionals on Spreading awareness
of Pharmacovigilance and stressing the
importance of Pharmacovigilance in
Patient Safety.
14

Thought Leadership
Apollo Research Bulletin
Publications : Express Healthcare
Apollo Research and Innovation has
achieved an unprecedented share of
voice in as many as 50+ media clips
across papers, journals and social media.
An example of contributing in thought
leaders is illustrated through a quote in
the “Genetic Diagnostics Special” column
of Express Healthcare. The article is a
general analysis on the genetic diagnosis
sector’s growth in India.
Read more: http://www.financialexpress.com/article/healthcare/digital-issue/
express-healthcare-vol-9-no-6-june-2015/80082/
15

Thought Leadership
Apollo Research Bulletin
Events and Conferences
ARI represented Apollo Hospitals in various events and conferences that were held in
2014 -15in India.
Some of the major conferences in which ARI was represented as a speaker/panelist
were :
FICCI Conference ‘Innovation Enabling Access’ 2014, New Delhi.
VCCircle Healthcare Investment Summit 2014, Mumbai.
DIA 2014 9th Annual India Conference 2014, Mumbai.
Wish Foundation: SCALE Healthcare Innovations Summit 2014, New Delhi.
CII Conference “India-Netherlands cooperation on Healthcare” 2014, New Delhi.
Indo US Technology Summit 2014, Noida.
ISB Leadership Summit 2014, Hyderabad.
CAMTech India Boot camp 2015, Bangalore.
ISCR Annual conference 2015, New Delhi.
MEDinISRAEL-3rd Medical Devices & Hit International Conference, Tel Aviv.
Nuviun Digital Health Live conference, Dubai.
IBC’s Healthcare Management Conference 2015, Singapore.
16

Social Initiative
Apollo Research Bulletin
Apollo Pharmacy & Apollo Hospitals Educational
and Research Foundation (AHERF) will supply free
medicines to the elderly
15 old age homes from Chennai would get assistance of free medicine delivery for
an year.
Apollo Group has undertaken this project to ensure that even the elderly have easy
access to medication.
Apollo’s CSR team along with Apollo pharmacy will work together for distribution of
medicines and accountability and will visit these homes twice a month for any scope
of improving the activities.
This initiative would subsequently be expanded to other cities and towns; Starting
with Delhi, 16 old age homes with over 990 inmates will benefit through the project.
17

Testimonials
Apollo Research Bulletin
We truly believe that the significance of our efforts & impact
is measured by testimonials from our stakeholders
Dr. Amitava Ray
Sr. Neurologist,
Apollo Hospitals
“As practicing clinicians we constantly come across problem that
do not have ready made solutions. I had a similar conundrum
about 2 years ago when I wanted to find a better way of diagnosing
brain tumours other than drilling holes in the head. I discussed
the problem with team ARI and 2 years later the product is about
to be launched and the first of its kind in the world. I would thank
team ARI without which it would not have been possible.”
“I finally had a chance to review the study results in detail and
they are almost better than even the BRIGGS study which we
use globally at the moment to talk about the findings over a 6
mo period with Unloader One. Kudos to your clinical team for a
fantastic and quality publication. I hope the AHERF team is as
satisfied with the results as we are !.”
Mr. Ajay Sasikumar Nair
Director of Marketing
Asia, Ossur
Dr. C. Venkata S. Ram
MD, Director , Apollo
Institute for Blood
Pressure Management
“I am writing to express my appreciation for AHERF for the
wonderful work they do in conducting high quality research,
innovation and medical education. Upon joining Apollo, my very
first research endeavor required the services of AHERF. Thanks, to
them, we have completed the largest clinical study in India using
24 hours Ambulatory blood pressure monitoring. The study was
completed in record time without any hurdles and I am extremely
happy to have been the PI of this study-first of its kind in India. At
Apollo, we are fortunate to have AHERF as a partner to conduct
world caliber research and innovations in the medical field.”
“In order to help nurses to respond timely to warning signs of
critical events, EarlySense monitoring system was installed in
our Oncology unit. it is a user friendly and convenient gadget
which helps nurses monitor heart rate, SPO2, respiratory rate
and patient movements. It has helped in reducing the number of
critical events on time thus preventing code blue situations. Many
doctors prefer to get their patients hooked on to the system.
Early warning signs has significantly improved the outcomes.
In my opinion this system enables nurses to recognize patient
deteriorations faster and helps clinicians for more effective
intervention.”
Ms. Usha Banerjeee
Group Nursing Director
Apollo Hospitals
18

Media Corner
Apollo Research Bulletin
19

Media Corner
Apollo Research Bulletin
20

About Us
Apollo Research Bulletin
Apollo Research and Innovations(ARI)
Apollo Research and Innovations (ARI) is
a division of Apollo Hospitals Enterprise
Limited (AHEL) spearheading research,
innovations and research related
educational programs. The vision of ARI
is to foster innovation in Technology,
Therapy, Processes and Business
models to achieve greater access,
affordable costs and global quality
standards. At Apollo, we believe in driving
clinical excellence and patient benefit
by incubating innovative enterprises
and encouraging Research & Innovation
Some of the key areas of innovations
include Convergence of Healthcare with
Life Sciences & Technology, Innovation in
Software, Innovation in Medical devices
and Innovation in Public Health.
Stemcyte India Pvt. Limited
Stemcyte India Private Limited is
a Company incorporated in 2007,
located in Apollo Hospital campus in
Ahmedabad. The Company is focussed
on establishing a hybrid public umbilical
stem cell bank to provide umbilical cord
blood units to transplant physicians
around the world and a private umbilical
stem cell bank to allow families in India
to store them for their family’s use. The
Company will also perform scientific
and clinical research to increase the
effectiveness, efficiency and use of
umbilical cord blood (UCB) stem cells.
The Company has developed and
maintained highest level of infrastructure
required for efficient storage of umbilical
cord blood banks as per the rigorous
standards of the law.
Sapien Biosciences
Sapien Biosciences is a joint venture
between Apollo Hospitals & Saarum
Innovations focusing on for novel
clinical and R&D applications. Sapien’s
primary objective is to build a highquality
bio-repository that integrates
ethically consented human samples
with associated medical, pathological
& diagnostic data and leverage this
resource to develop & deliver high-end
diagnostic applications.
Apollo Hospitals Educational and
Research Foundation (AHERF)
Apollo Hospitals Educational and
Research Foundation (AHERF) is an
autonomous organization recognized
by the Department of Scientific and
Industrial Research (DSIR) as a “Scientific
and Industrial Research Organization
(SIRO)”, to carry out research,
educational and training programs to
further basic and translational research.
We aspire to lead programs that have a
bearing on the health, social, economic
and indus trial needs of India
ARI interfaces with the above enterprises & several collaborators
whereby the project requires evaluating, validating & introducing
novel Healthcare solutions to Apollo
21

Drivers of Innovation
Apollo Research Bulletin
Mr. Seemant Jauhari
CEO – Research and
Innovations, Apollo
Hospitals
Mr. Seemant Jauhari is a visionary in healthcare research and innovations. He
has over 14 years of experience in General Management, Strategy, Business
Consulting & Innovations.
His forte has been commencing new initiatives and establishing enterprises
through innovative business models. He has been instrumental in architecting
new collaborations in Life Sciences, Genetics, Medical Devices and Software
converging multiple healthcare related interfaces. He has evaluated and
proposed various innovative and actionable solutions to reduce the cost
of health care and lead to improved health outcomes. Seemant represents
Apollo Hospitals at various international and Indian fora.
Seemant is a post graduate from the India School of Business (ISB),
Hyderabad and an engineer from the Birla Institute of Technology, Mesra. He
has had diverse experiences across business consulting at Ernst & Young,
Strategy & transformation at Nokia Solutions Networks and IT consulting at
Tata Consultancy Services.
A laboratory specialist and a Researcher with experience in clinical diagnostic
laboratories for 20 years, healthcare management for 5 years and clinical
research for 16 years.
Dr. Jayanthi Swaminathan has Masters degree in Biochemistry and Sociology
with an MBA in Pharmaceutical Management and PhD in Alternate System
of Medicine Research. She has to her credit, 5 years of experience as Senior
Clinical Biochemist at Christian Medical College Hospital Vellore, 4 years
of management experience with IIM Bangalore as Research Associate on
healthcare management research projects, 2 year experience as Quality
Assurance Manager for a domestic pharmaceutical firm manufacturing
diagnostics and biological and 15 years of experience as Scientific Officer in
laboratory services – Biochemistry Department of Apollo Hospitals Chennai.
She has about 16 years of clinical research experience with the Apollo Group
where she is in establishing, coordinating, conducting and managing 17
clinical trial sites across the Apollo Hospitals Group with over 850 clinical
trials to the credit.
Dr. Jayanthi Swaminathan
Sr. General Manager
ARI & AHERF
22
14 years of site man
17 operat

Scientific Advisory Team
Apollo Research Bulletin
Prof. Nirmal Ganguly
Chairman Research Task
Apollo Hospitals
Prof. Nirmal Ganguly is a distinguished Biotechnology Research Professor,
Department of Biotechnology. He is former Director General, ICMR and
Governing Body Member of 27 Indian institutes and Public Health Foundation
of India
Prof. Ganguly is MBBS, MD, DSc (hc), and Fellow of all the Indian Science
Academies; the Imperial College Faculty of Medicine, London and several other
prestigious institutions. Prof. Ganguly has published more than 775 research
papers and has supervised 130 Ph.D theses. His interest encompasses the
disciplines of Immunology, Biotechnology and Public Health. Dr. Ganguly is
recipient of 7 International and 112 National Awards. He has been honored
with the prestigious Padma Bhushan Award on 26th January, 2008 in the field
of “Medicine”.
Dr. Sita Naik, is an eminent Clinical Immunologist and a medical educationist,
with an undergraduate training at Maulana Azad Medical College, New Delhi
and post-graduate training in Pathology at Postgraduate Institute of Medical
Education and Research (PGIMER), Chandigarh. She had post-doctoral
training in Transplantation Immunology at the National Institutes of Health,
USA.
She has served on many committees of the Indian Medical Research Council,
Department of Biotechnology and Department of Science and Technology.
Her area of research has been immunology of infectious diseases and
autoimmunity. She has published 145 peer reviewed research papers and
contributed 36 book chapters. In recognition of her contribution she has
been elected Fellow of National Academy of Medical Sciences.
Dr Sita Naik
Scientific Advisor
AHERF
agement experience
ional sites
23

Innovation Doodles
Apollo Research Bulletin
We aspire to create an idea repository which could be leveraged to trigger clinical
innovations at Apollo. So if you have an idea please do contact us stating your name,
contact details, idea concept, problem and solution. Based on the information provided,
we will leverage on our in-house expertise and industry links to translate your idea to
reality through collaborations and creative business models.
You never know, your idea could make a fundamental
difference for the benefit of humanity!
24
Apollo
Research and
Innovations ( ARI)
Contact Us:
TEAM ARI
T: +91 44 28295465 | Email: jayanthi.s@aherf.net
Visit us at: www.aherf.org / www.apolloari.com